In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum

British Journal of Pharmacology

Volumn 125, Issue 7, 1998, Pages 1393-1395

  Croci, Tiziano ^a   Manara, Luciano ^a   Aureggi, Giulio ^a   Guagnini, Fabio ^a   Rinaldi Carmona, Murielle ^c   Maffrand, Jean Pierre ^c   Le Fur, Gérard ^c   Mukenge, Sylvain ^b   Ferla, Gianfranco ^b  

^a Research Center Sanofi Midy   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c SANOFI   (France)

Author keywords

Cannabinoids; CB1 receptors; Human ileum; SR 141716; SR 144528; WIN 55212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ATROPINE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CARBACHOL; N [ENDO 1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL] 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL)PYRAZOLE 3 CARBOXAMIDE; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE; RECEPTOR SUBTYPE; RIMONABANT; TETRODOTOXIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHOLINERGIC NERVE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; FEMALE; HUMAN; HUMAN TISSUE; ILEUM; INTESTINE MUSCLE; MALE; MUSCLE TWITCH; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION;

EID: 0031736065     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702190     Document Type: Article

References (15)

1. ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother., 14, 48-58.
2. CALIGNANO, A , LA RANA, G., MAKRYANNIS, A., LIN, S.Y., BELTRAMO, M. & PIOMELLI, D. (1997). Inhibition of intestinal motility by anandamide, an endogenous cannabinoid. Eur. J. Pharmacol., 340, R7-R8.
3. COLOMBO, G., AGABIO, R., LOBINA, C., REALI, R. & GESSA, G.L. (1998). Cannabinoid modulation of intestinal propulsion in mice. Eur. J. Pharmacol., 344, 67-69.
4. COUTTS, A.A. & PERTWEE, R.G. (1997). Inhibition by cannabinoid receptor agonists of acetylcholine release from guinea-pig myenteric plexus. Br. J. Pharmacol., 121, 1557-1566.
5. FELDER, C.C. & GLASS, M. (1998). Cannabinoid receptors and their endogenous agonists. Annu. Rev. Pharmacol. Toxicol., 38, 179-200.
6. CESSA, G.L., MASCIA, M.S., CASU, M.A. & CARTA, G. (1997). Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A. Eur. J. Pharmacol., 327, R1 -R2.
7. HERKENHAM, M. (1995). Localization of cannabinoid receptors in brain and periphery. In: Cannabinoid Receptors. Pertwee, R.G. (ed.) Academic Press, London, pp. 145-166.
8. 1 receptors. Br. J. Pharmacol., 284, 241-247.
9. 1 receptors in guinea-pig small intestine. Br. J. Pharmacol., 118, 2199-2205.
10. PERTWEE, R.G. GRIFFIN, G., LAINTON, J.A.H & HUFFMAN, J.W. (1995). Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens. Eur. J. Pharmacol., 284, 241-247.
11. RINALDI-CARMONA, M., BARTH, F., HEAULME, M., SHIRE, D., CALANDRA, B., CONGY, C. MARTINEZ, S., MARUANI, J., NELIAT, G., CAPUT, D . FERRARA, P., SOUBRIE, P., BRELIERE, J.C. & LE FUR, G. (1994). SR 141716A. a potent and selective antagonist of the cannabinoid receptor. FEBS Lett., 350, 240-244.
12. 2 Cannabinoid Receptor. J. Pharmacol. Exp. Ther., 284, 644-650.
13. RATKOVSKY, D.A. & REEDY, T.J. (1986). Choosing near-linear parameters in a four parameter logistic model for radioligand and related assay. Biometrics, 42, 575-582.
14. 1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis. Life Sci., 58, PL103-110.
15. TALLARIDA, R.J. & MURRAY, R.B. (1987). Manual of Pharmacological Calculations with Computer Programs. New York: Springer Verlag, pp. 58-61.